Ibrahim Raphiou

Ibrahim Raphiou, Ph.D. currently serves as the Global Clinical Program Lead at AstraZeneca since July 2022. Prior to this, Ibrahim held the position of Senior Director - Clinical Development - Medical Affairs at Seres Therapeutics starting from November 2021. With over 15 years of experience at GlaxoSmithKline, Ibrahim has held various roles such as Medical Affairs Scientific Director, Medical Affairs Scientific Manager, and Lead Clinical Development Scientist. Ibrahim earned their Doctor of Philosophy (Ph.D.) in Comparative Biomedical Sciences from North Carolina State University in 2002.